Cargando…
Hedgehog Pathway Inhibitors as Targeted Cancer Therapy and Strategies to Overcome Drug Resistance
Hedgehog (Hh) signaling is a highly conserved pathway that plays a vital role during embryonic development. Recently, uncontrolled activation of this pathway has been demonstrated in various types of cancer. Therefore, Hh pathway inhibitors have emerged as an important class of anti-cancer agents. U...
Autores principales: | Nguyen, Ngoc Minh, Cho, Jungsook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835893/ https://www.ncbi.nlm.nih.gov/pubmed/35163655 http://dx.doi.org/10.3390/ijms23031733 |
Ejemplares similares
-
Hedgehog pathway as a drug target: Smoothened inhibitors in development
por: Lin, Tara L, et al.
Publicado: (2012) -
Gut Microbiota and Alzheimer’s Disease: How to Study and Apply Their Relationship
por: Nguyen, Ngoc Minh, et al.
Publicado: (2023) -
Hypoxia-Inducible Factor-1: A Novel Therapeutic Target for the Management of Cancer, Drug Resistance, and Cancer-Related Pain
por: Bui, Bich Phuong, et al.
Publicado: (2022) -
Targeting DNA repair pathways to overcome cancer drug resistance
por: van Waardenburg, Robert C.A.M., et al.
Publicado: (2021) -
Novel Therapies and Strategies to Overcome Resistance to Anti-HER2-Targeted Drugs
por: Gámez-Chiachio, Manuel, et al.
Publicado: (2022)